Daily Briefing, Aug. 13
116% That’s how much blood disorder drug developer Global Blood Therapeutics shares rose Wednesday as the company became the latest biotechnology company with an IPO that received a powerful response from investors.
Global Blood Therapeutics Inc. says its treatment for sickle cell disease might stop red blood cells from becoming misshapen, treating the disease rather than its symptoms.
The National Institutes of Health says a stem cell transplant has been the only cure for sickle cell disease, but most patients are too old for a transplant or don’t can’t find a good enough genetic match.
Bumble Bee Foods agreed to pay $6 million to settle criminal charges Wednesday in the 2012 death of a worker who was cooked in an oven with tons of tuna.
Los Angeles District Attorney Jackie Lacey said the settlement is the largest payout in a California workplace-violation death.
Jose Melena died in a 270-degree oven at the company’s Santa Fe Springs plant after a co-worker mistakenly believed he was in the bathroom and filled a pressure cooker with 6 tons of canned tuna.
The Daily Briefing is compiled from San Francisco Chronicle staff and news services.